BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+835.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+835.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
819.8x
Strong expansion
Streak
5 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 13508.93% |
| 2024 | 97.55% |
| 2023 | 30.13% |
| 2022 | 16.48% |
| 2021 | -1.70% |
| 2020 | -75.71% |
| 2019 | -5.56% |
| 2018 | -64.11% |
| 2017 | -18.11% |
| 2016 | -23.23% |